• USAVET
  • 100 SERVICE DOGS
  • USAVET BIOTECH
  • 2022 STAND DOWN
  • CAMARADERIE CLUB
  • DONATE
  • VOLUNTEER
  • CONTACT
  • FOXHOLE SERVICES
  • More
    • USAVET
    • 100 SERVICE DOGS
    • USAVET BIOTECH
    • 2022 STAND DOWN
    • CAMARADERIE CLUB
    • DONATE
    • VOLUNTEER
    • CONTACT
    • FOXHOLE SERVICES
  • USAVET
  • 100 SERVICE DOGS
  • USAVET BIOTECH
  • 2022 STAND DOWN
  • CAMARADERIE CLUB
  • DONATE
  • VOLUNTEER
  • CONTACT
  • FOXHOLE SERVICES

usavet.org

usavet.orgusavet.orgusavet.org

SUPPORT OUR RESEARCH

Your Support will help us continue to discover novel alternatives to treating invisible wounds of combat and  opioid dependence.

Pay with PayPal or a debit/credit card

About Us

USAVET BIOTECH

 Accelerating Treatments for Veteran Health 

The Invisible War on the Brain

 Brain trauma similar to CTE from blast force is the signature injury of the Iraq and Afghanistan campaigns, afflicting hundreds of thousands of U.S. combat personnel. Although unseen, the damage strikes deeply into a soldier’s mind and psyche 

cannabis used to treat PTSD

Recent research has documented high rates of comorbidity between cannabis use disorders and posttraumatic stress disorder (PTSD) in veterans. However, despite possible links between PTSD and cannabis use, relatively little is known about cannabis use in veterans who present for PTSD treatment, particularly among samples not diagnosed with a substance use disorder.

CB1 and CB2 Receptors

 Internally produced cannabinoids (called endocannabinoids) and phytocannabinoids interact with the Endocannabinoid System through specialized cellular receptors (largely in the nervous system) known as CB1 and CB2 receptors, discovered in the 1990s. CB1 receptors are situated in the brain and central nervous system. In contrast, CB2 receptors are found in the immune system’s organs and tissues, such as the thymus, skin, lymph nodes, bone marrow, spleen, colon, and mucous membranes of the sinus, anus, genitals, nose, bladder, and throat. Both can utilize cannabinoids in one way or another 

cannabinoids in the pathophysiology and potential treatment of PTSD

  

Integrative view of eCBs and exogenous cannabinoids in the pathophysiology and potential treatment of PTSD and related processes. Low levels of AEA and/or 2-AG, triggered by stress or pre-existing due to genetic factors, are associated with a myriad of adverse behavioral and physiological consequences including an increase susceptibility to developing trauma-related psychopathology such as PTSD,TBI & CTE Therapeutic eCBaugmentation may be able to reverse these pre-existing or stress-induced deficiencies via inhibition of FAAH or MAGL activity (FAAHi and MAGLi, respectively). 


Copyright © 2023 usavet.org - All Rights Reserved.

  • Terms and Conditions
  • Privacy Policy
  • V1 RESEARCH
  • VETERAN MADE

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept